-
PacBio Generates Accurate Long Read Sequences Through Circular Consensus Sequencing
Feb 25, 2019, 10:10 AM by Michael CroftFull storyBio-IT World | PacBio has developed a protocol based on single-molecule, circular consensus sequencing to generate accurate long read sequences. The company hopes this approach will provide an alternative to the limited read lengths of short read sequencing and the limited read accuracy of long read sequencing.
-
Lygos Partners with Leading Materials Scientists at the University of Massachusetts to Expand Applications of its Bio-Malonic™ Acid Product Family
Feb 21, 2019, 13:44 PM by Michael CroftBERKELEY, CA, UNITED STATES - Feb 20, 2019 - Lygos Inc., a full-stack producer of petroleum-free specialty chemicals that deliver high-value performance without the environmental toxicity, today announced a new partnership with the Center for University of Massachusetts-Industry Research on Polymers (CUMIRP), the nations oldest National Science Foundation Industry / University Cooperative Research Center dedicated to polymer researchFull story -
D4
Feb 21, 2019, 10:43 AM by Michael CroftBOSTON, MA - Mar 20, 2019 - This is the first conference to specifically help pharma and biotech companies build and execute a scalable, sustainable and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods and ways of looking at the data life cycle that drive incredible value within pharma R&DxFull story -
The Imperative For Open Data Access And Sharing: A Progress Report
Feb 21, 2019, 09:30 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Clinical data sharing creates new value, with benefits to science and society. There has been a great deal of activity, which is a positive step, yet current approaches are somewhat fragmented in terms of process and openness.
-
Linum Labs announces Molecule, a software platform and marketplace to accelerate innovation in pharma
Feb 21, 2019, 08:22 AM by Michael Croft- Feb 21, 2019 - Linum Labs, a software development studio that builds blockchain-based solutions, has announced Molecule, a market platform to accelerate innovation in the pharmaceutical and biotech industryFull story -
Certara Launches Version 19.1 of its D360 Scientific Informatics Platform
Feb 21, 2019, 08:10 AM by Michael CroftPRINCETON, NJ - Feb 21, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the launch of version 19Full story -
Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies
Feb 21, 2019, 04:37 AM by Michael CroftBOURNEMOUTH, UK - Feb 21, 2019 - Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announce a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicinesFull story -
What’s New Out West: Preview Of Bio-IT World’s First West Coast Event
Feb 20, 2019, 12:30 PM by Michael CroftFull storyBio-IT World | This year Bio-IT World is taking the show on the road. After 17 years in Boston, the Bio-IT World Conference & Expo is visiting the West Coast with the launch of Bio-IT World West, a program within the Molecular Medicine Tri-Conference focused on bioinformatics, data management, and machine learning.
-
Greenphire to Address Global Site Payment Transformation at 10th Annual Summit for Clinical Ops Executives (SCOPE) 2019
Feb 19, 2019, 17:32 PM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Feb 19, 2019 - Greenphire, the global leader in financial software for clinical trials, announced today that its CEO, Jim Murphy, will co-present Global Site Payment Transformation alongside a leading industry sponsor at the upcoming Summit for Clinical Ops Executives (SCOPE) 2019 in Orlando, FloridaFull story -
RCH Solutions Expands Coverage with the Hiring of Industry Veteran Frank Iafrato
Feb 19, 2019, 13:08 PM by Michael CroftWAYNE, PA, UNITED STATES - Feb 19, 2019 - RCH Solutions (RCH), a global provider of computational science expertise for Life Sciences and Healthcare firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales and Business DevelopmentFull story -
Empire Genomics Appoints New Leadership and Relocates Headquarters to Support Growing Demand from Clinical Laboratories Around the World
Feb 19, 2019, 09:36 AM by Michael CroftWILLIAMSVILLE, NY, UNITED STATES - Feb 19, 2019 - Empire Genomics Inc., the premier global provider of clinical and custom labeled molecular probes, today announced the appointments of Andy Watson as Chief Executive Officer and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NYFull story -
Quanticate Appoints Paula Finch as Senior Vice President, Project Delivery
Feb 19, 2019, 08:24 AM by Michael CroftLONDON, UNITED KINGDOM - Feb 19, 2019 - Quanticate, a leading global data-focused clinical research organisation (CRO), has appointed of Paula Finch as senior vice president of project deliveryFull story -
Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials
Feb 19, 2019, 08:17 AM by Michael CroftCAMBRIDGE, MA, US - Feb 19, 2019 - Shimmer, a global leader in wearable technology for research applications, today announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participantsFull story -
No Black Box: Securing Our Data Analytics
Feb 18, 2019, 14:15 PM by Michael CroftFull storyBio-IT World | Data scientists and lawyers have fundamentally different goals. A data scientist wants as much relevant data as possible. A lawyer wants to limit unauthorized use of the data. How do you create a symbiotic relationship? How do you mitigate the concerns of both? A company called Immuta is building a data management and permissions platform that will please both.
-
Karger Publishers Invests in the Biomedical Discovery Company Quertle
Feb 15, 2019, 15:20 PM by Michael CroftBASEL, SWITZERLAND - Feb 15, 2019 - At the beginning of 2019, Karger became a major shareholder in the award-winning company that has developed the first biomedical-specific AI Big Data Visual Analytics EnginexFull story -
IBM, Broad Institute Launch Initiative Using Genomics & AI To Predict Risk Of Cardiovascular Disease
Feb 14, 2019, 11:05 AM by Michael CroftFull storyBio-IT World News Brief | IBM Watson Health and the Broad Institute are expanding their partnership to help clinicians better predict the possibility of serious cardiovascular diseases.
-
Recipharm announces all its facilities are ready for EU serialisation
Feb 14, 2019, 05:19 AM by Michael CroftSTOCKHOLM, SWEDEN - Feb 14, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), today announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadlineFull story -
Data Is The Key Ingredient To Digital Transformation
Feb 13, 2019, 12:45 PM by Michael CroftFull storyBio-IT World Contributed Commentary | The pharmaceutical industry needs a data transformation before it can realize its digital transformation—and most companies recognize the urgency.
-
Chemspace and LabNetwork collaborate to extend access to chemical databases
Feb 13, 2019, 07:08 AM by Michael Croft, RIGA, LATVIA AND SHANGHAI, CHINA - Feb 13, 2019 - Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreementFull story -
Victa Biotherapeutics Appoints Donald W. Kufe to Board of Directors
Feb 12, 2019, 09:11 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Feb 12, 2019 - HiFiBiO Therapeutics, a world leader in the discovery and development of therapeutic antibodies enabled by unique single-cell profiling and full immune repertoire screening, today announced Donald WFull story